The effect of primary renal disease upon outcomes after renal transplant

Author:

Garland Shona1ORCID,Pullerits Kairi1,Chukwu Chukwuma A23ORCID,Chinnadurai Rajkumar23,Middleton Rachel23,Kalra Philip A23

Affiliation:

1. University of Manchester Manchester UK

2. Faculty of Biology, Medicine and Health, Division of cardiovascular medicine The University of Manchester Manchester UK

3. Department of Nephrology Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust Salford UK

Abstract

AbstractBackgroundThis study investigated whether nature of primary renal disease affects clinical outcomes after renal transplantation at a single center in the United Kingdom.MethodsThis was a retrospective cohort study of 961 renal transplant recipients followed up at a large renal center from 2000 to 2020. Separation of diseases responsible for end‐stage kidney disease included glomerulonephritis, diabetic kidney disease, hypertensive nephropathy, autosomal dominant polycystic kidney disease, unknown cause, other causes and chronic pyelonephritis. Outcome data included graft loss, cardiovascular events, malignancy, post‐transplant diabetes mellitus and death, analyzed according to primary disease type.ResultsThe mean age at transplantation was 47.3 years. During a mean follow‐up of 7.6 years, 18% of the overall cohort died corresponding to an annualised mortality rate of 2.3%. Death with a functioning graft occurred at a rate of 2.1% per annum, with the highest incidence observed in in patients with diabetic kidney disease (4.1%/year). Post‐transplant cardiovascular events occurred in 21% of recipients (2.8% per year), again highest in recipients with diabetic kidney disease (5.1%/year) and hypertensive nephropathy (4.5%/year). Post‐transplant diabetes mellitus manifested in 19% of the cohort at an annualized rate of2.1% while cancer incidence stood at 9% with an annualized rate of 1.1% . Graft loss occurred in 6.8% of recipients at the rate of1.2% per year with chronic allograft injury, acute rejection and recurrent glomerulonephritis being the predominant causative factors. Median + IQR dialysis‐free survival of the whole cohort was 16.2 (9.9 ‐ > 20) years, being shortest for diabetic kidney disease (11.0 years) and greatest for autosomal dominant polycystic kidney disease (18.2 years) .The collective mean decline in eGFR over time was ‐1.14ml/min/year. Recipients with Pre‐transplant diabetic kidney disease exhibited the fastest rate of decline(‐2.1ml/min/year) a statistically significant difference in comparison to the other native kidney diseases with Autosomal dominant polycystic kidney disease exhibiting the lowest rate of decline(‐0.05ml/min/year)ConclusionPrimary renal disease can influence the outcome after renal transplantation, with patients with prior diabetic kidney disease having the poorest outcome in terms of dialysis‐free survival and loss of transplant function. Autosomal polycystic kidney disease, other cause and unknown cause had the best outcomes compared to other primary renal disease groups.

Publisher

Wiley

Reference14 articles.

1. Oxford Handbook of Clinical Medicine

2. nhsbt‐kidney‐transplantation‐annual‐report‐2018‐19.pdf [Internet]. [cited 2021 May 25]. Available from:https://nhsbtdbe.blob.core.windows.net/umbraco‐assets‐corp/16778/nhsbt‐kidney‐transplantation‐annual‐report‐2018‐19.pdf

3. Causes of death after renal transplantation

4. Outcomes of Renal Transplantation After End-Stage Renal Disease Due to Diabetic Nephropathy: A Single-Center Experience

5. Autosomal-Dominant Polycystic Kidney Disease and Kidney Transplantation: Experience of a Single Center

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3